I am well aware of Immunogen and their technology. Why did their CEO jump to another biotech company if their technology was so great.
Tell me another immuno company that had a 100% response rate with her2 breast cancer!
You are totally wrong about TPIV. Glynn Wilson has been working with TAP for several years at the Mayo Clinic and he knows exactly what he has here with TAP. An immno technology that works better than any other in the pipeline.
This company is on the launch pad and is about to get launched into space!
Google "Dr. Wilfred A. Jefferies." His scientific team at the University of British Columbia discovered the TAP technology and turned it over to the Mayo Clinic for further development. To say the early trials were impressive is an understatement.
TAP is in very good hands and the current group of people that are developing the TAP technology are going to show why TAP is superior to other immuno type technologies.
Do not sell this stock. If you do, it will be the biggest mistake you ever made in your life.
ITKG. Read up on this company and you will see what potential this company has with major companies like BASF and Delphi getting ready to market their ElectriPlast light weight conductive plastic! Been watching and investing in this company for 10 years and this is going to be the breakout year for this company.
Lets just say I have followed this company and their technology for several years and own a large amount of their stock.
This company not only has huge potential in cancer, it has huge potential in vaccines.
When the real potential of their technology emerges, this company is going to make many a shareholder a large amount of money. Nuff said!